Literature DB >> 28593446

C3 glomerulonephritis with a severe crescentic phenotype.

Aishwarya Ravindran1, Fernando C Fervenza2, Richard J H Smith3, Sanjeev Sethi4.   

Abstract

BACKGROUND: C3 glomerulopathy (C3G) is rare type of glomerulonephritis resulting from the glomerular deposition of C3 due to dysregulation of the alternative pathway of complement. It is further subdivided into C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), depending on the ultrastructural features. C3GN usually presents with a membranoproliferative pattern of injury. Crescents may or may not be present. However, we have noted a severe necrotizing and crescentic glomerulonephritis in a small subset of C3GN patients. CASE DIAGNOSIS/TREATMENT: We present the clinical features, kidney biopsy findings, complement evaluation, treatment, and follow-up of four C3GN patients. We also compare the findings with four DDD patients with a severe necrotizing and crescentic glomerulonephritis. The patients were young and presented with hematuria and proteinuria. The biopsy was remarkable for the large number of crescents, in association with bright glomerular staining for C3. The patients were treated with steroids/immunosuppressive drugs. Three of the 4 C3GN patients and 2 of the 4 DDD patients showed stable renal function at follow-up. We find remarkable similarities between our C3GN patients with crescents and the previously described entity of juvenile acute nonproliferative glomerulonephritis.
CONCLUSIONS: To summarize, C3G with a severe crescentic phenotype is rare, affects children and young adults, and has a variable response to steroid and immunosuppressive treatment. It is important to recognize this rare cause of crescentic glomerulonephritis so that appropriate evaluation and treatment can be carried out.

Entities:  

Keywords:  C3 glomerulonephritis; C3 glomerulopathy; Crescents; Dense deposit disease; Kidney

Mesh:

Substances:

Year:  2017        PMID: 28593446     DOI: 10.1007/s00467-017-3702-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Membranoproliferative glomerulonephritis--a new look at an old entity.

Authors:  Sanjeev Sethi; Fernando C Fervenza
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

2.  Toward a working definition of C3 glomerulopathy by immunofluorescence.

Authors:  Jean Hou; Glen S Markowitz; Andrew S Bomback; Gerald B Appel; Leal C Herlitz; M Barry Stokes; Vivette D D'Agati
Journal:  Kidney Int       Date:  2013-09-25       Impact factor: 10.612

3.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Authors:  M A Abrera-Abeleda; C Nishimura; J L H Smith; S Sethi; J L McRae; B F Murphy; G Silvestri; C Skerka; M Józsi; P F Zipfel; G S Hageman; R J H Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

4.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

5.  Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Authors:  Aude Servais; Véronique Frémeaux-Bacchi; Moglie Lequintrec; Rémi Salomon; Jacques Blouin; Bertrand Knebelmann; Jean-Pierre Grünfeld; Philippe Lesavre; Laure-Hélène Noël; Fadi Fakhouri
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

6.  Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Samih H Nasr; Nelson Leung; Julie Vrana; Carl Cramer; Carla M Nester; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

7.  Acute non-proliferative glomerulitis: a cause of renal failure unique to children.

Authors:  C D West; A J McAdams; D P Witte
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

Review 8.  Histopathology of MPGN and C3 glomerulopathies.

Authors:  H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

9.  Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.

Authors:  Fernando C Fervenza; Richard J H Smith; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2012-04-26       Impact factor: 8.860

10.  Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Ladan Zand; Nicole C Meyer; Nicolò Borsa; Samih H Nasr; Richard J H Smith
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

View more
  4 in total

1.  Clinicopathological features of C3 glomerulopathy in children: a single-center experience.

Authors:  Keri A Drake; Natalie Ellington; Jyothsna Gattineni; Jose R Torrealba; Allen R Hendricks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

2.  C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome.

Authors:  Shane A Bobart; Sanjeev Sethi; Fernando C Fervenza
Journal:  Kidney Med       Date:  2019-01-14

Review 3.  The glomerular crescent: triggers, evolution, resolution, and implications for therapy.

Authors:  Lidia Anguiano; Renate Kain; Hans-Joachim Anders
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-05       Impact factor: 3.416

4.  Infection-related Glomerulonephritis and C3 Glomerulonephritis - Similar Yet Dissimilar: A Case Report and Brief Review of Current Literature.

Authors:  Gajapathiraju Chamarthi; William L Clapp; Harini Bejjanki; Jena Auerbach; Abhilash Koratala
Journal:  Cureus       Date:  2020-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.